CCRN - Cross Country Healt... Stock Analysis | Stock Taper
Logo
Cross Country Healthcare, Inc.

CCRN

Cross Country Healthcare, Inc. NASDAQ
$9.97 -0.70% (-0.07)

Market Cap $324.48 M
52w High $14.99
52w Low $7.43
P/E -3.40
Volume 408.18K
Outstanding Shares 32.32M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $236.76M $21.84M $-82.93M -35.03% $-2.56 $10.99M
Q3-2025 $250.05M $56.9M $-4.77M -1.91% $-0.15 $-993K
Q2-2025 $274.07M $61.86M $-6.66M -2.43% $-0.2 $-1.08M
Q1-2025 $293.41M $59.63M $-490K -0.17% $-0.02 $4.42M
Q4-2024 $309.94M $65.42M $-3.75M -1.21% $-0.12 $3.98M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $108.74M $448.95M $126.13M $322.82M
Q3-2025 $99.13M $538.23M $130.09M $408.14M
Q2-2025 $81.19M $553.82M $141.58M $412.24M
Q1-2025 $80.7M $576.24M $158.03M $418.21M
Q4-2024 $81.63M $589.25M $170.29M $418.96M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $0 $18.24M $-2.12M $-6.52M $9.61M $16.12M
Q3-2025 $-4.77M $20.11M $-2.19M $-6K $17.94M $17.92M
Q2-2025 $-6.66M $4.22M $-1.97M $-1.76M $496K $2.25M
Q1-2025 $-490K $5.68M $-1.89M $-4.72M $-936K $3.79M
Q4-2024 $-3.75M $24.23M $-2.53M $-4.08M $17.61M $21.7M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Other Services
Other Services
$10.00M $10.00M $10.00M $10.00M

Q3 2024 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Cross Country Healthcare, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key positives include a strong balance sheet with net cash, ample liquidity, and modest debt, which provides resilience and flexibility. The company has an established brand in healthcare staffing, a large and diverse clinician network, and deep relationships with health systems built over many years. Its proprietary Intellify platform and broader digital investments give it a clear technology story and the potential for more recurring, higher-margin revenues. Positive operating and free cash flow in the latest period, despite poor accounting earnings, offer additional financial breathing room.

! Risks

Major concerns center on the reported collapse in revenue and large accounting losses, which, if representative of reality rather than data quirks, would indicate extreme operational stress and an unsustainable business model. High ongoing operating costs relative to current reported revenue, significant asset exposure to goodwill and intangibles, and the lack of visible capital spending all add to the risk profile. Competitive pressure from larger staffing and tech-enabled rivals, health system cost-cutting, and potential regulatory changes could further compress margins and volumes. Execution risk around scaling Intellify, entering new verticals, and possibly licensing the platform also remains significant.

Outlook

The forward view is mixed and highly dependent on clarifying the true underlying revenue and profitability trajectory. On one hand, a strong cash position, low leverage, and meaningful technology assets position Cross Country to adapt, invest, and pursue growth in workforce solutions, platform expansion, and adjacent staffing markets. On the other hand, the current income statement snapshot and intense industry competition suggest that the path forward may involve continued restructuring, margin pressure, and the need to prove that Intellify-driven solutions can deliver durable growth and profitability. Overall, the company has strategic tools and financial resources, but the near-to-medium-term outlook remains uncertain until the disconnect between accounting losses, reported revenue, and positive cash flow is better understood.